The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Results of a comprehensive pharmacogenetic analysis of dihydropyrimidine dehydrogenase in patients treated with fluoropyrimidines and patterns of polymorphisms partially related to treatment tolerability.
Marzia Del Re
No relevant relationships to disclose
Marta Schirripa
No relevant relationships to disclose
Angela Michelucci
No relevant relationships to disclose
Marta Cubelli
No relevant relationships to disclose
Silvia Magagna
No relevant relationships to disclose
Santino Minichillo
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
Paolo Simi
No relevant relationships to disclose
Claudio Zamagni
No relevant relationships to disclose
Alfredo Falcone
No relevant relationships to disclose
Romano Danesi
No relevant relationships to disclose